Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational age with hypoxic-ischemic encephalopathy. Death or moderate or severe ...

Researchers at UHealth-;the University of Miami Health System and the University of Miami Miller School of Medicine have shown that, in two cases, COVID-19 infection breached the placenta and caused ...

Study shows that perinatal arterial ischemic stroke often coexists with hypoxic-ischemic encephalopathy in infants receiving therapeutic hypothermia This article clearly shows that there are children ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal hypoxic-ischemic encephalopathy (HIE), which affects one to three in 1,000 live ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...

Please provide your email address to receive an email when new articles are posted on . High-dose erythropoietin did not improve outcomes for infants with hypoxic ischemic encephalopathy. Controlled ...

Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with neonatal hypoxic ischemic encephalopathy (HIE), a phase III randomized trial ...

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to ...